Mehalik Daniella 4
4 · PSYCHEMEDICS CORP · Filed Jan 24, 2024
Insider Transaction Report
Form 4
Mehalik Daniella
Vice President - Finance
Transactions
- Award
Stock Option (Right to Buy)
2024-01-22+35,000→ 35,000 totalExercise: $3.40Exp: 2034-01-22→ Common Stock, $.005 Par Value (35,000 underlying) - Award
Stock Option (Right to Buy)
2024-01-22+70,000→ 70,000 totalExercise: $3.40Exp: 2034-01-22→ Common Stock, $.005 Par Value (70,000 underlying)
Footnotes (2)
- [F1]The option becomes exercisable with respect to 50% of the shares on January 22, 2025 and with respect to the remaining 50% on January 22, 2026.
- [F2]The option becomes exercisable, if at all, in two 35,000 share increments. The first increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2027 shall have exceeded $5.50. The second increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2028 shall have exceeded $6.50.